Article
Characterisation of the E. coli HMS174 and BLR host cell proteome to guide purification process development
20 May 2023
Abstract excerpt
Mass-spectrometry-based proteomics is increasingly employed to monitor purification processes or to detect critical host cell proteins in the final drug substance. This approach is inherently unbiased and can be used to identify individual host cell proteins without prior knowledge. In process development for the purification of new biopharmaceuticals, such as protein subunit vaccines, a broader knowledge of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
